Weight-loss drugs seek acceptance from patients and physicians

March 17, 2015 12:51 PM

2 0

Weight-loss drugs seek acceptance from patients and physicians

A new generation of weight-loss medications that suppress patients’ appetites and make them feel full is facing reluctance among patients because of safety issues with past diet drugs.

The latest, Saxenda, from Novo Nordisk A/S, was approved by U.S. regulators late last year and hasn’t hit pharmacies yet. Other new appetite-suppressing prescription drugs on the market include Qsymia, Belviq and Contrave. Sales of the drugs have been slower than expected.

Read more

To category page

Loading...